Christopher Gibson reports multiple Class A share sales

Christopher C. Gibson reported multiple sales of Class A shares.

Rhea-AI Filing Summary

Christopher C. Gibson reported multiple sales of Class A shares. The filing lists six transactions of 40,000 Class A shares each on 11/19/2025, 12/04/2025, 12/19/2025, 01/05/2026, 01/20/2026, and 02/04/2026, with reported proceeds of 166,400.00, 185,200.00, 180,000.00, 170,000.00, 178,800.00, and 164,800.00, respectively.

Insights

Corporate Governance Analyst

Insider reported a series of routine sales across late 2025 and early 2026.

The filing lists six discrete sales by Christopher C. Gibson, each of 40,000 Class A shares, reported with per-transaction gross proceeds in the range shown in the excerpt. This is a factual disclosure of transactions rather than a commentary on motive.

Timing and cash-flow treatment are tied to each dated transaction; subsequent filings would show any withholding or broker-related adjustments if applicable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Christopher C. Gibson disclose in the Form 144 for RXRX?

He disclosed six sales of Class A shares, each of 40,000 shares on specified dates. The filing lists sales on 11/19/2025, 12/04/2025, 12/19/2025, 01/05/2026, 01/20/2026, and 02/04/2026 with the dollar amounts shown for each transaction.

How many shares did Gibson sell per transaction in the RXRX filing?

Each transaction reported by Gibson involved 40,000 Class A shares. The excerpt shows six identical share counts across the listed sale dates, with corresponding gross-dollar figures for each sale.

What proceeds were reported for the sales in the RXRX Form 144?

The filing shows reported proceeds per sale: 166,400.00, 185,200.00, 180,000.00, 170,000.00, 178,800.00, and 164,800.00. These amounts appear next to each dated sale in the excerpt.

Do the Form 144 entries show the reason for the RXRX share sales?

The excerpt lists the transactions and labels earlier Class A shares as 'Founders Shares' and 'Compensation' for issuer context. It does not provide a narrative explanation of Gibson’s reasons for the sales in the provided content.

Where is Gibson's reported address and broker information listed in the filing?

The filing lists Gibson’s address as 41 S Rio Grande Street, Salt Lake City, UT 84101, and shows Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI. Broker and address details are included in the excerpt lines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 10:27 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001856369
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RECURSION PHARMACEUTICALS, INC.
SEC File Number	001-40323
Address of Issuer	41S RIO GRANDE STREET SALT LAKE CITY UTAH 84101
Phone	(385) 269-0203
Name of Person for Whose Account the Securities are To Be Sold	Gibson Christopher
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	40000	138400.00	514895802	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/01/2016	Founders Shares	Issuer			40000	09/01/2016	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	11/19/2025	40000	166400.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	12/04/2025	40000	185200.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	12/19/2025	40000	180000.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	01/05/2026	40000	170000.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	01/20/2026	40000	178800.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	02/04/2026	40000	164800.00

144: Remarks and Signature

Remarks
Date of Notice	02/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Christopher C. Gibson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)